$12.91
-0.03-0.23%
Last update: 11:54 AM
15 minutes delayed
Comments
Loading...
Cidara Therapeutics
CDTXNASDAQ
Cidara Therapeutics (NASDAQ:CDTX) Stock, Insider Trading Activity
Cidara Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Cidara Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 11, 2024, Jeffrey Stein, the company's PRESIDENT & CEO purchased 8K shares for $13.21 each.
Ownership Statistics for Cidara Therapeutics Inc
Institutional Shares Held
1.002M
Institutional Percentage Held
8.89%
| Jun 11, 2024 | Jeffrey Stein | PRESIDENT & CEO | 8.00K | $13.21 | $105.68K | BUY | 42.83% | 26.68K | Jun 07 | View |
| Mar 12, 2024 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -21.03K | $0.67 | -$14.09K | SELL | -7.48% | 260.17K | Mar 11 | View |
| Mar 12, 2024 | Taylor Sandison | CHIEF MEDICAL OFFICER | -20.66K | $0.67 | -$13.84K | SELL | -5.62% | 347.10K | Mar 11 | View |
| Mar 12, 2024 | Shane Ward | COO & CLO | -20.47K | $0.67 | -$13.71K | SELL | -9.34% | 198.77K | Mar 11 | View |
| Mar 12, 2024 | Preetam Shah | CFO & CBO | -18.93K | $0.67 | -$12.68K | SELL | -7.69% | 227.21K | Mar 11 | View |
| Sep 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.47K | $0.95 | -$17.51K | SELL | -6.25% | 277.19K | Sep 11 | View |
| Sep 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.79K | $0.95 | -$17.81K | SELL | -4.91% | 363.76K | Sep 11 | View |
| Aug 14, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 10.00K | $0.97 | $9.70K | BUY | 3.50% | 295.66K | Aug 14 | View |
| Aug 08, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50.00K | $0.96 | $47.88K | BUY | 15.45% | 373.61K | Aug 08 | View |
| Mar 27, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50.00K | $1.04 | $51.85K | BUY | 18.27% | 323.61K | Mar 27 | View |
| Mar 13, 2023 | Shane Ward | COO & CLO | -4.33K | $1.53 | -$6.62K | SELL | -4.87% | 84.58K | Mar 13 | View |
| Mar 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -7.56K | $1.53 | -$11.57K | SELL | -3.80% | 191.66K | Mar 13 | View |
| Mar 13, 2023 | Preetam Shah | CFO & CBO | -6.65K | $1.53 | -$10.17K | SELL | -4.29% | 148.14K | Mar 13 | View |
| Mar 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -7.20K | $1.53 | -$11.02K | SELL | -2.44% | 288.55K | Mar 13 | View |
| Jan 27, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -11.81K | $1.20 | -$14.18K | SELL | -5.60% | 199.22K | Jan 12 | View |
| Sep 19, 2022 | Preetam Shah | CFO & CBO | 34.36K | $0.77 | -$12.03K | SELL-OPTIONS | 29.51% | 150.79K | Sep 15 - Sep 19 | View |
| Sep 13, 2022 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.48K | $0.68 | -$12.66K | SELL | -5.96% | 291.75K | Sep 12 | View |
| Sep 13, 2022 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.16K | $0.68 | -$12.44K | SELL | -8.06% | 207.04K | Sep 12 | View |
| Sep 13, 2022 | Paul Daruwala | CHIEF OPERATING OFFICER | -16.20K | $0.68 | -$11.09K | SELL | -6.83% | 221.10K | Sep 12 | View |
| Mar 23, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -654.00 | $0.81 | -$529.74 | SELL | -1.31% | 49.37K | Mar 21 | View |
| Mar 11, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -945.00 | $0.71 | -$670.95 | SELL | -1.85% | 50.02K | Mar 11 | View |
| Jan 07, 2022 | Paul Daruwala | CHIEF OPERATING OFFICER | 4.77K | $1.25 | -$6.42K | SELL-OPTIONS | 2.61% | 187.30K | Dec 29 - Jan 05 | View |
| Jan 07, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -154.00 | $1.25 | -$520.00 | SELL | -0.30% | 50.97K | Dec 29 - Jan 05 | View |
| Jan 07, 2022 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 849.00 | $1.25 | -$1.56K | SELL-OPTIONS | 0.51% | 168.70K | Dec 29 - Jan 05 | View |
| Nov 15, 2021 | Jeffrey Stein | PRESIDENT & CEO | 50.00K | $1.59 | $79.53K | BUY | 10.92% | 507.89K | Nov 12 | View |
| Nov 15, 2021 | Preetam Shah | CFO & CBO | 20.00K | $1.54 | $30.80K | BUY | ∞ | 20.00K | Nov 12 | View |
| Sep 14, 2021 | Timothy R Franson | DIRECTOR | 7.00K | $2.12 | $14.82K | BUY | 175.00% | 11.00K | Sep 13 | View |
| Aug 19, 2021 | Jeffrey Stein | PRESIDENT & CEO | 50.00K | $1.74 | $86.75K | BUY | 12.26% | 457.89K | Aug 18 - Aug 19 | View |
| Apr 05, 2021 | Neil Abdollahian | CHIEF BUSINESS OFFICER | -837.00 | $2.26 | -$9.82K | SELL | -1.44% | 57.47K | Jan 05 - Apr 01 | View |
| Apr 05, 2021 | Paul Daruwala | CHIEF OPERATING OFFICER | -2.06K | $2.16 | -$7.49K | SELL | -3.92% | 50.53K | Jan 05 - Apr 01 | View |
| Apr 05, 2021 | Jessica Oien | GENERAL COUNSEL & SECRETARY | 799.00 | $2.41 | -$4.83K | GRANT | 11.47% | 7.76K | Jan 05 - Apr 01 | View |
| Nov 12, 2020 | Jeffrey Stein | — | 50.00K | $2.00 | $100.02K | PURCHASE | 15.94% | 363.59K | Nov 10 | View |
| Nov 12, 2020 | James Levine | — | 50.00K | $2.01 | $100.72K | PURCHASE | 75.95% | 115.83K | Nov 10 | View |
| Jan 06, 2020 | Jessica Oien | — | -834.00 | $3.86 | -$3.22K | SELL | -10.69% | 6.96K | Jan 02 | View |
| Jan 06, 2020 | Neil Abdollahian | — | -2.34K | $3.42 | -$8.00K | SELL | -4.37% | 51.25K | Jan 03 | View |
| Jan 06, 2020 | Paul Daruwala | — | -2.34K | $3.42 | -$8.00K | SELL | -4.19% | 53.53K | Jan 03 | View |
| Oct 03, 2019 | Paul Daruwala | CHIEF OPERATING OFFICER | -3.29K | $1.88 | -$6.19K | SELL | -5.57% | 55.87K | Oct 02 | View |
| Oct 03, 2019 | Neil Abdollahian | CHIEF BUSINESS OFFICER | -7.28K | $1.98 | -$14.42K | SELL | -12.81% | 49.59K | Oct 01 | View |
| Oct 01, 2019 | Jessica Oien | GENERAL COUNSEL & SECRETARY | -1.00K | $1.86 | -$1.86K | SELL | -11.38% | 7.80K | Sep 27 | View |
| Sep 26, 2019 | Jeffrey Stein | PRESIDENT & CEO | 52.50K | $1.91 | $100.10K | BUY | 27.80% | 241.33K | Sep 24 | View |
| Sep 26, 2019 | James Levine | CHIEF FINANCIAL OFFICER | 30.00K | $1.91 | $57.24K | BUY | 17.14% | 205.00K | Sep 24 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.